Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Salicylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.91 |
| ▸ | HPGD | P15428 | 6/20 | 0.91 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.91 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | CA1 | P00915 | 2/20 | 0.58 |
| ▸ | CA9 | Q16790 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.58 |
| ▸ | CA4 | P22748 | 1/20 | 0.58 |
| ▸ | CA6 | P23280 | 1/20 | 0.58 |
| ▸ | CA7 | P43166 | 1/20 | 0.58 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | MPO | P05164 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Salicylic Acid SCHEMBL6249450 | 0.97 | KDM4E (0.95) | KDM4EHPGDALDH1A1SMN1; SMN2CA1 | |
| Salicylic Acid SCHEMBL2511998 | 0.95 | KDM4E (0.91) | KDM4EHPGDALDH1A1SMN1; SMN2CA1 | |
| Salicylic Acid SCHEMBL11599872 | 0.95 | KDM4E (0.91) | KDM4EHPGDALDH1A1SMN1; SMN2CA1 | |
| Salicylic Acid SCHEMBL546852 | 0.95 | KDM4E (0.91) | KDM4EHPGDALDH1A1SMN1; SMN2CA1 | |
| Salicylic Acid SCHEMBL11514957 | 0.95 | KDM4E (0.91) | KDM4EHPGDALDH1A1SMN1; SMN2CA1 | |
| Salicylic Acid SCHEMBL9981 | 0.95 | KDM4E (0.91) | KDM4EHPGDALDH1A1SMN1; SMN2CA1 | |
| Salicylic Acid SCHEMBL458273 | 0.95 | KDM4E (0.91) | KDM4EHPGDALDH1A1SMN1; SMN2CA1 | |
| Salicylic Acid SCHEMBL3132735 | 0.95 | KDM4E (0.91) | KDM4EHPGDALDH1A1SMN1; SMN2CA1 | |
| Salicylic Acid SCHEMBL7738091 | 0.95 | KDM4E (0.91) | KDM4EHPGDALDH1A1SMN1; SMN2CA1 | |
| Salicylic Acid SCHEMBL12477385 | 0.95 | KDM4E (0.91) | KDM4EHPGDALDH1A1SMN1; SMN2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140154342-A1 | SANDALWOOD OIL AND ITS USES RELATED TO SKIN DISORDERS | SANTALIS PHARMACEUTICALS INC. (US) | 2014-06-05 | — | — | US | claimed |
| EP-2736504-A1 | SANDALWOOD OIL AND ITS USES RELATED TO SKIN DISORDERS | Santalis Pharmaceuticals Inc. (US) | 2014-06-04 | — | — | EP | claimed |
| WO-2013016656-A1 | SANDALWOOD OIL AND ITS USES RELATED TO SKIN DISORDERS | SANTALIS PHARMACEUTICALS INC. (US) | 2013-01-31 | — | — | WO | claimed |
| JP-60091998-A | — | — | None | — | — | JP | disclosed |
| EP-2274327-B1 | CRYSTAL STRUCTURE OF HUMAN SORTILIN AND USES THEREOF FOR IDENTIFYING LIGANDS TO SORTILIN | H LUNDBECK AS (DK) | 2019-03-27 | — | — | EP | disclosed |
| US-9932687-B2 | High throughput screening of crystallization of materials | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2018-04-03 | — | — | US | disclosed |
| CN-103796650-B | Sandalwood oil and its purposes related to skin disease | 桑塔利斯医药公司 | 2017-12-15 | — | — | CN | disclosed |
| US-20160184824-A1 | HIGH THROUGHPUT SCREENING OF CRYSTALLIZATION OF MATERIALS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-06-30 | — | — | US | disclosed |
| US-9205423-B2 | High throughput screening of crystallization of materials | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2015-12-08 | — | — | US | disclosed |
| US-20150152348-A1 | SYSTEMS AND METHODS FOR COLLECTING, TRANSPORTING AND REPURPOSING OR DESTROYING UNUSED PHARMACEUTICALS | SHARPS COMPLIANCE, INC. OF TEXAS | 2015-06-04 | — | — | US | disclosed |
| CN-102247685-B | Harmless treatment process for mercury-containing waste dangerous chemicals | SHANGHAI FUTUO ENVIRONMENT TECHNOLOGY CO LTD | 2015-02-25 | — | — | CN | disclosed |
| WO-2004094020-A2 | CRYSTAL GROWTH DEVICES AND SYSTEMS, AND METHODS FOR USING SAME | FLUIDIGM CORPORATION (US) | 2004-11-04 | — | — | WO | disclosed |
| EP-1392484-A4 | HIGH THROUGHPUT SCREENING OF CRYSTALIZATION OF MATERIALS | CALIFORNIA INST OF TECHN (US) | 2004-07-28 | — | — | EP | disclosed |
| US-20040115731-A1 | Microfluidic protein crystallography | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2004-06-17 | — | — | US | disclosed |
| EP-1392484-A2 | HIGH THROUGHPUT SCREENING OF CRYSTALIZATION OF MATERIALS | California Institute of Technology (US) | 2004-03-03 | — | — | EP | disclosed |
| US-20030061687-A1 | High throughput screening of crystallization materials | CALIFORNIA INSTITUTE OF TECHNOLOGY, A CALIFORNIA CORPORATION | 2003-04-03 | — | — | US | disclosed |
| WO-2002082047-A2 | HIGH THROUGHPUT SCREENING OF CRYSTALLIZATION OF MATERIALS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2002-10-17 | — | — | WO | disclosed |
| US-5849560-A | Proteases causing degradation of amyloid β-protein precursor | TRUSTEES OF BOSTON UNIVERSITY (US) | 1998-12-15 | — | — | US | disclosed |
| JP-S6091998-A | NOVEL ENZYMATIC MEASUREMENT OF D-3-HYDROXYBUTYRIC ACID AND ACETOACETIC ACID IN HUMORS, URINE AND MEASUREMENT REAGENT FOR IT | SHIGETA YUKIO | 1985-05-23 | — | — | JP | disclosed |
| US-4256848-A | Synergistic polyurethane co-catalysts which are a combination of an organo-mercuric compound and a zinc salt of an alkyl carboxylic acid | BASF WYANDOTTE CORPORATION (US) | 1981-03-17 | — | — | US | disclosed |